Pharma

Your Article Summary

See Latest Articles

FDA Advisory Committee makes favorable recommendation for Cervarix, GlaxoSmithKlines candidate cervical cancer vaccine
GlaxoSmithKline, 09/10/09

GlaxoSmithKline announced that the U.S. Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee voted that clinical data support both the efficacy and safety of CERVARIX, the company's candidate cervical cancer vaccine.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Ustekinumab (Stelara): First-in-class human monoclonal antibody approved for treatment of moderate-to-severe plaque psoriasis
Formulary , 12/02/09

Safety concerns slow new drug review and approval processes
Formulary , 12/02/09

Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09

 See all of Drug/Product Approvals